234 related articles for article (PubMed ID: 38070496)
1. Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro.
Rosario R; Stewart HL; Spears N; Telfer EE; Anderson RA
Hum Reprod; 2024 Feb; 39(2):382-392. PubMed ID: 38070496
[TBL] [Abstract][Full Text] [Related]
2. Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve.
Kashi O; Roness H; Spector I; Derech-Haim S; Meirow D
Hum Reprod; 2023 Jun; 38(6):1086-1098. PubMed ID: 37015102
[TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian hormone inhibits activation and growth of bovine ovarian follicles in vitro and is localized to growing follicles.
Yang MY; Cushman RA; Fortune JE
Mol Hum Reprod; 2017 May; 23(5):282-291. PubMed ID: 28333275
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.
Zhou L; Xie Y; Li S; Liang Y; Qiu Q; Lin H; Zhang Q
J Ovarian Res; 2017 Aug; 10(1):56. PubMed ID: 28814333
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
[TBL] [Abstract][Full Text] [Related]
6. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
7. Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice.
Li J; Long H; Cong Y; Gao H; Lyu Q; Yu S; Kuang Y
Reprod Biol Endocrinol; 2021 Apr; 19(1):63. PubMed ID: 33892727
[TBL] [Abstract][Full Text] [Related]
8. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin prevents cyclophosphamide-induced ovarian follicular loss and potentially inhibits tumour proliferation in a breast cancer xenograft mouse model.
Tanaka Y; Amano T; Nakamura A; Yoshino F; Takebayashi A; Takahashi A; Yamanaka H; Inatomi A; Hanada T; Yoneoka Y; Tsuji S; Murakami T
Hum Reprod; 2024 May; ():. PubMed ID: 38734930
[TBL] [Abstract][Full Text] [Related]
11. Matrix-free 3D culture supports human follicular development from the unilaminar to the antral stage in vitro yielding morphologically normal metaphase II oocytes.
Xu F; Lawson MS; Bean Y; Ting AY; Pejovic T; De Geest K; Moffitt M; Mitalipov SM; Xu J
Hum Reprod; 2021 Apr; 36(5):1326-1338. PubMed ID: 33681988
[TBL] [Abstract][Full Text] [Related]
12. The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model.
Del Castillo LM; Buigues A; Rossi V; Soriano MJ; Martinez J; De Felici M; Lamsira HK; Di Rella F; Klinger FG; Pellicer A; Herraiz S
Hum Reprod; 2021 Aug; 36(9):2514-2528. PubMed ID: 34333622
[TBL] [Abstract][Full Text] [Related]
13. Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue.
Devos M; Diaz Vidal P; Bouziotis J; Anckaert E; Dolmans MM; Demeestere I
Hum Reprod; 2023 Mar; 38(3):408-420. PubMed ID: 36723906
[TBL] [Abstract][Full Text] [Related]
14. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation.
Grosbois J; Demeestere I
Hum Reprod; 2018 Sep; 33(9):1705-1714. PubMed ID: 30032281
[TBL] [Abstract][Full Text] [Related]
16. Direct actions of androgen, estrogen and anti-Müllerian hormone on primate secondary follicle development in the absence of FSH in vitro.
Baba T; Ting AY; Tkachenko O; Xu J; Stouffer RL
Hum Reprod; 2017 Dec; 32(12):2456-2464. PubMed ID: 29077845
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
[TBL] [Abstract][Full Text] [Related]
18. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
Friis Wang N; Bogstad JW; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
Hum Reprod; 2023 Sep; 38(9):1807-1815. PubMed ID: 37354554
[TBL] [Abstract][Full Text] [Related]
19. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
20. Non-growing follicle density is increased following adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary.
McLaughlin M; Kelsey TW; Wallace WH; Anderson RA; Telfer EE
Hum Reprod; 2017 Jan; 32(1):165-174. PubMed ID: 27923859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
